Vialwirebiotech, curated
July 23, 2026, 5:28 AM
May 15, 2026
- 5:15 PM · STAT News
- 4:00 PM · FT — Pharmaceuticals4:00 PM‘Botox’ boom shows no sign of sagging as inflation hits luxury sector — FT — Pharmaceuticals
- 1:41 PM · STAT News
- 1:31 PM · Endpoints News1:31 PMAmgen expands crackdown on what it says is misuse of 340B program — Endpoints News
- 12:07 PM · Pharmaceutical Technology12:07 PMECO 2026: indirect comparison favours Wegovy pill over Foundayo — Pharmaceutical Technology
- 12:00 PM · BioWorld12:00 PMEU reaches Critical Medicines Act pact to tackle drug shortages — BioWorld
- 12:00 PM · BioWorld12:00 PMSonomind raises €20M for ultrasound neuromodulation technology — BioWorld
- 12:00 PM · BioWorld12:00 PMValidity of Actelion patent hinges on temperature — BioWorld
- 11:58 AM · BioPharma Dive11:58 AMFDA hold puts Aardvark Prader-Willi drug in limbo — BioPharma Dive
- 11:47 AM · BioPharma Dive11:47 AMSupreme Court preserves access to abortion pill by mail — BioPharma Dive
- 11:36 AM · BioPharma Dive11:36 AMBiotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers — BioPharma Dive
- 11:30 AM · Endpoints News11:30 AMCandel reports prostate cancer drug's long-term data ahead of FDA filing — Endpoints News
- 9:17 AM · Pharmaceutical Executive9:17 AM<![CDATA[FDA Approves Fasenra for Hypereosinophilic Syndrome]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMHCW Biologics’ HCW11-040 prevents bronchopulmonary dysplasia — BioWorld
- 9:00 AM · BioWorld9:00 AMKSI-028 suppresses STING-driven inflammation — BioWorld
- 9:00 AM · BioWorld9:00 AMCamp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model — BioWorld
- 8:00 AM · Labiotech (EU)8:00 AMCAR-T therapy for stiff person syndrome nears approval — Labiotech (EU)
- 7:00 AM · Endpoints News7:00 AMAndrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirement — Endpoints News
- 6:45 AM · Endpoints News6:45 AM#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live — Endpoints News
- 6:44 AM · Pharmaceutical Technology6:44 AMArna Pharma and Slate Run complete JV for new US company — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMCollaboration set to develop neuroinflammation therapeutics — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMCanadian companies to partner on novel antibody therapies — Drug Discovery World
- 4:42 AM · Pharmaceutical Technology4:42 AMKyowa Kirin secures FDA approval for Crysvita dosing update — Pharmaceutical Technology
May 14, 2026
- 2:50 PM · Endpoints News2:50 PM#ASGCT26: Encoded's gene therapy reduced seizures in Dravet syndrome — Endpoints News
- 12:09 PM · Drug Discovery World12:09 PMInfinitopes appoints CSO to advance immuno-oncology pipeline — Drug Discovery World
- 12:00 PM · Endpoints News12:00 PMDrugmakers have to go through rigorous tests to get a lower tariff rate — Endpoints News
- 10:31 AM · Endpoints News10:31 AMAstraZeneca follows Merck with Phase 3 win in bladder cancer — Endpoints News
- 10:10 AM · Endpoints News10:10 AMMacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attack — Endpoints News
- 9:54 AM · Drug Discovery World9:54 AMGene editing technology could treat Hepatitis B — Drug Discovery World
- 9:23 AM · Pharmaceutical Executive9:23 AM<![CDATA[FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax]]> — Pharmaceutical Executive
- 7:32 AM · Endpoints News7:32 AMBiogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy — Endpoints News
- 7:00 AM · Endpoints News7:00 AMRegenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval — Endpoints News
- 6:31 AM · Endpoints News6:31 AMBeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta — Endpoints News
- 6:24 AM · Drug Discovery World6:24 AMMHRA to open Northern Ireland hub to boost life sciences — Drug Discovery World